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Abstract Myogenesis is characterized by membrane fusion and
accumulation of muscle specific proteins. We have previously
shown that nitric oxide acts as a messenger for membrane fusion.
Here we show that inhibitors of the proteasome, such as
lactacystin, reversibly block both the fusion of L6 myoblasts
and the accumulation of muscle specific proteins, such as myosin
heavy chain (MHC). The inhibitors also reversibly prevented the
induction of the NF-UB activity, which is required for the
expression of nitric oxide synthase (NOS). Moreover, the
inhibition of the NF-UB activity occurred in parallel with that
of the NOS activity upon treatment with increasing concentra-
tions of lactacystin. While pyrrolidine dithiocarbamate, an
inhibitor of NF-UB, blocked both membrane fusion and
accumulation of MHC, NG-monomethyl-L-arginine, a specific
inhibitor of NOS, inhibited only the fusion. These results suggest
that the proteasome plays an essential role in the regulation of
myogenic differentiation through the activation of NF-UB and
that the target of NF-UB for the expression of muscle specific
proteins is distinct from that for myoblast fusion.
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1. Introduction
Myogenesis, a well-de¢ned di¡erentiation event, is charac-
terized by fusion of mononucleated myoblasts into multi-
nucleated myotubes [1,2]. Concurrent with the morphological
di¡erentiation, a large number of muscle speci¢c proteins,
such as K-actin and myosin, accumulate during the myogenic
process [3,4]. Protein breakdown appears to play an important
role in regulation of muscle cell di¡erentiation [5]. For exam-
ple, calpain and its speci¢c inhibitor protein, called calpas-
tatin, have been implicated in the control of myoblast fusion
[6^9].
The 26S proteasome that is the ATP-dependent protease in
eukaryotes consists of two multimeric components: the cata-
lytic 20S core and the regulatory 19S ATPase [10]. This en-
zyme complex degrades target proteins that are conjugated
with ubiquitin, such as cyclins and transcription factors (e.g.
Jun, Fos, and NF-UB/IUB) [11]. Thus, the ubiquitin-dependent
protein breakdown catalyzed by the 26S proteasome plays a
critical function in regulation of a variety of cellular processes,
including cell cycle regulation, gene expression, cell di¡eren-
tiation, and immune response. In addition, we have shown
that the subunit pattern and the poly-L-lysine activated casein
degrading activity of the 20S proteasome core dramatically
changes during development of chick embryonic muscle [12].
NF-UB is a transcription factor that can be activated in
many cell types and regulates a wide variety of genes involved
in immune function and development [13,14]. For example, it
positively regulates the expression of the inducible form of
nitric oxide synthase (NOS), which catalyzes the conversion
of L-arginine to NO and L-citrulline [15,16]. NO is a short-
lived free radical which serves as a messenger for diverse
physiological functions, such as smooth muscle relaxation,
neurotransmission, and antibacterial activity [17,18]. In the
absence of inducer, NF-UB is trapped in cytoplasm by an
inhibitor protein known as IUB. In the presence of inducer,
however, IUB is phosphorylated, ubiquitinated, and degraded
by the 26S proteasome, to release NF-UB, which can then be
translocated into the nucleus for expression of NOS as well as
others [19,20]. Thus, the 26S proteasome is essential for acti-
vation of NF-UB.
We have previously demonstrated that NO acts as a mes-
senger for myoblast fusion [21] and that the NF-UB dependent
expression of NOS is required for membrane fusion of chick
embryonic myoblasts [22]. In the present study, we examined
whether the 26S proteasome plays an essential role in NF-UB
mediated regulation of myogenic di¡erentiation, using speci¢c
inhibitors of the 26S proteasome.
2. Materials and methods
2.1. Cell culture
The L6 rat myogenic cell line [23] was obtained from American
Type Culture Collection. The cells were plated on plastic tissue culture
dishes at a concentration of 1.5U104 cells/ml in Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% fetal bovine serum [24].
Three days after cell seeding, the culture medium was changed to a
di¡erentiation medium, which contained 5% horse serum instead of
10% fetal bovine serum. When needed, proteasome inhibitors were
treated to the culture medium at the time of medium change. The
time of the medium change was regarded as day 0 of culture (see
below). The extent of myoblast fusion was expressed as the number
of nuclei in fused cells as a percentage of the total number of nuclei in
10 randomly chosen ¢elds under a microscope. Cells containing more
than three nuclei were regarded as fused cells.
2.2. Electrophoretic mobility shift assay
An oligonucleotide probe containing the decameric consensus NF-
UB binding site sequence [22,25] was synthesized using an automated
DNA synthesizer (Applied Biosystem, model 384A). The probe was
end-labeled with [Q-32P]ATP using T4 kinase. The nuclear extracts of
L6 cells were prepared as described [26]. Binding reactions (in 20 Wl
total) were performed by incubating 10 Wg of the nuclear extract with
a reaction bu¡er containing 20 mM HEPES (pH 7.9), 1 mM EDTA,
60 mM KCl, 12% (v/v) glycerol, and 4 Wg poly(dI-dC)Wpoly(dI-dC) for
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10 min at 4‡C and then with the probe (about 80 000 cpm) for the
next 25 min at the same temperature. The reaction mixtures were
electrophoresed on 5% (w/v) polyacrylamide gels in high ionic
strength bu¡er containing 50 mM Tris (pH 8.5), 380 mM glycine,
and 2 mM EDTA [27]. The gels were then dried and autoradio-
graphed.
2.3. Assays
The activity of NOS was determined by monitoring the conversion
of [14C]arginine (Amersham) into [14C]citrulline as described [28]. Re-
action mixtures (0.2 ml) contained 50 mM HEPES (pH 7.4), 0.2 WCi
of L-[14C]arginine, 1 mM NADPH, 10 Wg/ml of calmodulin, 1.25 mM
CaCl2, 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsul-
fonyl £uoride, 10 WM leupeptin, 1.5 WM pepstatin, 10 Wg/ml of apro-
tinin, and appropriate amounts of myoblast extracts. After incubation
for 10 min at 37‡C, the reaction was terminated by adding 20 Wl of
20% (v/v) HClO4. The samples were applied to 1 ml columns of AG
50W (U8, Na form) and eluted with 2 ml of distilled deionized
water. Aliquots of the eluates (i.e. [14C]citrulline) were then counted
for radioactivity.
3. Results and discussion
3.1. E¡ects of proteasome inhibitors on myogenic
di¡erentiation
In order to determine whether the proteasome is involved in
di¡erentiation of L6 myoblasts, the cells were cultured in the
presence and absence of 1 WM lactacystin, 100 nM N-carbo-
benzoxy-Leu-Leu-norvalinal (MG115), or 10 nM N-carboben-
zoxy-Ile-Glu-(O-t-butyl)-Ala-leucinal (PSI), which speci¢cally
inhibit the proteasome [29^31]. As shown in Fig. 1A, these
reagents strongly inhibited myoblast fusion, although this in-
hibitory e¡ect was slowly diminished upon prolonged culture
(e.g. at day 3). At the concentrations tested, they showed little
or no cytotoxic e¡ect, as assessed by the rate of [3H]thymidine
incorporation (data not shown). We then examined whether
the inhibitory e¡ect on myoblast fusion can be reversed upon
removal of the reagents. The cells cultured for 24 h in the
presence of 1 WM lactacystin were freed of the inhibitor by
changing the medium, and further cultured for the next 48 h.
Fig. 1B shows that myoblast fusion can be resumed upon
removal of the inhibitor. Similar data were obtained when
the cells were treated with MG115 and PSI, following removal
of the inhibitors (data not shown). These results indicate that
the proteasome inhibitors block myoblast fusion and their
e¡ects are reversible.
To examine whether the proteasome inhibitors also in£u-
ence accumulation of muscle speci¢c proteins during myogen-
esis, L6 myoblasts were cultured in the presence and absence
of lactacystin, MG115, or PSI as above. After the culture, the
cell lysates were prepared and subjected to immunoblot anal-
ysis using the anti-myosin heavy chain (MHC) monoclonal
antibody (MF-20). Fig. 2 shows that the accumulation of
MHC is signi¢cantly reduced upon the treatment (‘+’ lanes)
but can be resumed upon removal of the inhibitors (‘3’ lanes).
These results indicate that the proteasome inhibitors block not
only the membrane fusion but also the synthesis of muscle
speci¢c proteins and that both of their e¡ects are reversible.
Thus, it seems that the proteasome plays a critical role in
regulation of myogenic di¡erentiation.
3.2. E¡ects of proteasome inhibitors on the activation of NF-UB
Proteasomes are known to degrade ubiquitinated IUB for
activation of NF-UB [19,20]. In addition, we have previously
shown that NO acts as a messenger for myoblast fusion and
that NF-UB dependent expression of NOS is essential for
membrane fusion of chick embryonic myoblasts [21,22].
Therefore, we ¢rst examined the expression pattern of NF-
UB in nuclear extracts of L6 myoblasts during the time course
of myogenic di¡erentiation by probing it with a radiolabeled
oligonucleotide containing the decameric consensus NF-UB
binding site. As shown in Fig. 3A, the NF-UB activity was
dramatically increased 24 h after the change of the culture
medium to di¡erentiation medium (i.e. at day 1) and rapidly
disappeared 48 h after the medium change (i.e. from day 2).
Furthermore, the transient increase in the NF-UB activity oc-
curred just prior to the onset of myoblast fusion (see Fig. 1A)
as well as of accumulation of muscle speci¢c proteins (see
below). Thus, the timely increase in the NF-UB activity ap-
pears to be critical for myogenic di¡erentiation.
On the other hand, when the cells were treated with lacta-
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Fig. 1. E¡ects of the proteasome inhibitors on membrane fusion of
L6 myoblasts. A: The cells were plated and cultured for 72 h as de-
scribed in Section 2. After the culture (i.e. at day 0), the culture me-
dium was changed to di¡erentiation medium. The cells were then
further cultured for various periods in the absence (a) and presence
of 1 WM lactacystin (b), 10 nM PSI (R), and 100 nM MG115 (O).
The extent of myoblast fusion was then determined. B: The cells
that had been incubated in the absence (lane C) and presence of
1 WM lactacystin (lane L) for 24 h were freed of the reagent (lane
F) by changing to fresh di¡erentiation medium and further cultured
for the next 48 h.
Fig. 2. E¡ects of the proteasome inhibitors on accumulation of my-
osin heavy chain. After the medium change, the cells were cultured
in the absence of the inhibitors for 24 h (lane C1) or 72 h (lane
C2). They were also cultured in the presence of the inhibitors (‘+’
lanes) for 72 h. To determine whether their e¡ects are reversible,
the cells treated with the inhibitors for 24 h were freed of the re-
agents by changing the medium and further cultured for the next 48
h (‘3’ lanes). The cell lysates were then prepared, electrophoresed in
10% polyacrylamide slab gels under denaturing conditions, and sub-
jected to immunoblot analysis using a monoclonal antibody (MF-
20) raised against myosin heavy chain (MHC). The numbers at the
bottom of the gel indicate the days after cell plating. L, lactacystin
(1 WM); P, PSI (10 nM); M, MG115 (100 nM).
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cystin at the time of medium change, little or no increase in
the NF-UB activity was observed at day 1 (Fig. 3B). These
results indicate that the proteasome activity, most likely
against IUB, is responsible for induction of the NF-UB activity
during myogenic di¡erentiation. Upon prolonged culture of
the cells in the presence of the inhibitor, however, the NF-UB
activity gradually increased although to a level much less than
that seen without the inhibitor. This slight increase in the level
of NF-UB activity might be due to slow metabolism of lacta-
cystin in the cells, and is in accordance with the ¢nding that
the cells resume myoblast fusion during the late period of
culture although to low extents (see Fig. 1A, day 3).
We then examined whether the other proteasome inhibitors
can also block the induction of the NF-UB activity and
whether the inhibitory e¡ects can be reversed upon removal
of the reagents. The cells were cultured for 24 h in the pres-
ence of the inhibitors, freed of the inhibitor by changing the
medium, and further cultured for the next 24 h. As shown in
Fig. 4, the binding of NF-UB to the oligonucleotide probe was
signi¢cantly reduced upon treatment of the inhibitors (‘+’
lanes) but could be restored upon their removal (‘3’ lanes).
These results again show that the NF-UB activity is mediated
by the action of the proteasome, which is most likely to be the
degradation of ubiquitinated IUB.
In order to determine whether the NF-UB activity that in-
creases just prior to myoblast fusion is also related to the
expression of genes for muscle speci¢c proteins, the cells
were cultured for various periods in the absence and presence
of 1 WM pyrrolidine dithiocarbamate (PDTC), an inhibitor of
NF-UB [32]. After the culture, the cell lysates were prepared
and subjected to immunoblot analysis as above using the anti-
MHC monoclonal antibody. Table 1 shows that the treatment
of PDTC strongly diminishes the accumulation of MHC. In
addition, the same treatment prevented both NF-UB activa-
tion and membrane fusion in the cells cultured for 24 h and 72
h, respectively (data not shown). Thus, it appears that the
synthesis of muscle speci¢c proteins also requires NF-UB ac-
tivity.
3.3. E¡ect of lactacystin on the induction of NOS activity
We have recently shown that both the activity and protein
level of NOS also transiently and markedly increase just be-
fore fusion and its expression requires NF-UB activity in cul-
tured chick myoblasts [21,22]. A similar change in NOS ac-
tivity was observed with L6 myoblasts (data not shown).
Therefore, we examined whether the proteasome inhibitors
can also block the induction of NOS. L6 myoblasts were
treated with increasing concentrations of lactacystin at the
time of medium change. Twenty-four hours after the treat-
ment, soluble and nuclear extracts were prepared from the
cells and assayed for the activities of NOS and NF-UB, re-
spectively. Upon the treatment, the NOS activity was inhib-
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Table 1
E¡ect of PDTC on the accumulation of MHC
Culture time Relative amount of MHC in the cells cultured
(%)
without PDTC with PDTC
Day 1 14 þ 3 3 þ 1
Day 2 65 þ 1 17 þ 4
Day 3 100 21 þ 3
The cells were cultured in the absence and presence of 1 WM PDTC.
At the indicated times of culture, the cell lysates were prepared and
subjected to immunoblot analysis as in Fig. 2. The bands correspond-
ing to MHC were scanned using a densitometer (Pharmacia), and the
intensity of the band seen with the cells cultured for 72 h without
PDTC was regarded as 100% and the others are values relative to
that.
Fig. 4. E¡ects of the proteasome inhibitors on NF-UB activity. After
the medium change, the cells were cultured in the presence of the
inhibitors (‘+’ lanes) for 24 h. To determine whether their e¡ects
are reversible, the cells that had been treated with the inhibitors for
24 h were freed of the reagents by changing the medium and further
cultured for the next 24 h (‘3’ lanes). As a control, the cells were
also cultured for 24 h in the absence of any inhibitor. Nuclear ex-
tracts were prepared from the cells and subjected to electrophoretic
mobility shift assay as in Fig. 3. The bands corresponding to the
complex of NF-UB and the radioactive probe were scanned using a
phosphoimager (Fuji), and the intensity of the band seen without
any inhibitor (lane C) was regarded as 100% and the others are val-
ues relative to it. L, lactacystin (1 WM); P, PSI (10 nM); M,
MG115 (100 nM).
Fig. 3. E¡ect of lactacystin on the induction of NF-UB activity dur-
ing myogenesis. The cells were cultured for various periods as in
Fig. 1 but in the absence (A) and presence of 1 WM lactacystin (B).
Nuclear extracts were prepared from the cells at the indicated cul-
ture periods and subjected to electrophoretic mobility shift assay for
their NF-UB binding activity using the radiolabeled palindromic
NF-UB binding site as a probe as described in Section 2. The num-
bers at the top of the gel show the day after the medium change.
NF-UB, NF-UB/DNA complex; NS, nonspeci¢c; Free, unbound
probe. The nucleotide sequence of the probe is: 5P-AGTTGAGGG-
GACTTTCCCAGGC-3P, 3P-TCAACTCCCCTGAAAGGGTCCG-
5P. Note that the fast-migrating bands (indicated as NS), but not
the NF-UB binding activity, disappear when the same assays were
performed in the presence of an unlabeled, mutant probe, in which
the underlined bases (G and C) are replaced by C and G, respec-
tively (data not shown).
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ited in a dose dependent fashion and its inhibition occurred in
parallel with the reduction in NF-UB activity (Table 2). When
the cells were further incubated for the next 48 h under the
same culture condition, membrane fusion was also inhibited
in a dose dependent fashion. These results indicate that pro-
teasome is involved in the signaling pathway for the NO-
mediated membrane fusion of L6 myoblasts through activa-
tion of NF-UB, which leads to expression of NOS.
We have previously shown that the casein degrading activ-
ity of the 20S proteasome, which is activated by poly-L-lysine,
markedly increases in chick skeletal muscle tissues obtained
from 11^17 day embryos [12], at which period the fused my-
otubes accumulate most actively [33]. We have also demon-
strated that the subunit pattern of the 20S proteasome dra-
matically changes during development of the embryonic
muscle [12]. Thus, it is possible that an increase in the 20S
proteasome activity, perhaps due to the change in its subunit
pattern, and hence in the activity of the 26S proteasome may
also occur in cultured L6 myoblasts that are competent for
membrane fusion and that the increased activity may be re-
sponsible for IUB degradation and hence for activation of NF-
UB. The free form of NF-UB is then translocated into the
nucleus, where it induces NOS for generation of NO, a mes-
senger for myoblast fusion.
However, NOS does not seem to be involved in the expres-
sion of genes for muscle speci¢c proteins. We have previously
shown that NG-monomethyl-L-arginine, a speci¢c inhibitor of
NOS, inhibits membrane fusion but shows little or no e¡ect
on the accumulation of creatine kinase and acetylcholine re-
ceptor in chick embryonic myoblasts [21]. Similar results were
obtained when the same reagent was treated to L6 myoblasts
(data not shown). Thus, it appears that the target of NF-UB
for the expression of muscle speci¢c proteins is distinct from
that for myoblast fusion, although both myogenic processes
require the activity of proteasome in the activation of NF-UB.
More study is required for understanding the molecular mech-
anism underlying how NF-UB in£uences the expression of the
muscle speci¢c proteins.
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Table 2
E¡ects of increasing concentrations of lactacystin on the induction
of NF-UB and NOS and on myoblast fusion
Concentration (WM) Relative activity (%) of Membrane
fusion (%)
NF-UB NOS
None 100 100 100
0.01 72 þ 2 75 þ 4 83 þ 5
0.1 48 þ 9 51 þ 8 57 þ 2
1.0 30 þ 7 27 þ 3 36 þ 4
L6 myoblasts were cultured as in Fig. 1 but in the absence and pres-
ence of increasing concentrations of lactacystin. Soluble and nuclear
extracts were prepared from the cells cultured for 24 h and assayed for
their activities of NF-UB and NOS, respectively. The cells were also
continuously cultured for 72 h for determination of fusion. The activ-
ities of NF-UB and NOS and the cell fusion determined in the absence
of lactacystin were expressed as 100% and the others are values rela-
tive to it. Each value represents the mean þ S.E.M. of data obtained
from three separate experiments.
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